Synthesis of diacylated trehalose sulfates: candidates for a tuberculosis vaccine.
Guiard
Julie
J
Département des Mécanismes Moléculaires des Infections, Mycobactériennes, Institut de Pharmacologie et de Biologie Structurale du CNRS, UMR 5089, Université de Toulouse III, 205 route de Narbonne, 31077 Toulouse Cedex, France.
Collmann
Anthony
A
Gilleron
Martine
M
Mori
Lucia
L
De Libero
Gennaro
G
Prandi
Jacques
J
Puzo
Germain
G
D000942:Antigens, Bacterial / Q000737:chemistry* / Q000276:immunology / Q000494:pharmacology; D006017:Glycolipids / Q000138:chemical synthesis* / Q000737:chemistry / Q000276:immunology; D006801:Humans; D008213:Lymphocyte Activation; D009169:Mycobacterium tuberculosis / Q000276:immunology*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D014199:Trehalose / Q000031:analogs & derivatives* / Q000737:chemistry / Q000276:immunology; D032581:Tuberculosis Vaccines / Q000138:chemical synthesis* / Q000276:immunology / Q000494:pharmacology
C087075:2,3-diacyltrehalose-2'-sulfate; D000942:Antigens, Bacterial; D006017:Glycolipids; D032581:Tuberculosis Vaccines; C011117:sulfoglycolipids; D014199:Trehalose